2-100964091-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002518.4(NPAS2):c.632C>T(p.Thr211Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000316 in 1,613,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_002518.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPAS2 | ENST00000335681.10 | c.632C>T | p.Thr211Ile | missense_variant | Exon 8 of 21 | 1 | NM_002518.4 | ENSP00000338283.5 | ||
NPAS2 | ENST00000486017.5 | n.679C>T | non_coding_transcript_exon_variant | Exon 7 of 7 | 3 | |||||
NPAS2 | ENST00000492373.1 | n.409C>T | non_coding_transcript_exon_variant | Exon 5 of 6 | 4 | |||||
NPAS2 | ENST00000448812.5 | c.566-4190C>T | intron_variant | Intron 5 of 6 | 5 | ENSP00000388528.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152170Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251454 AF XY: 0.0000368 show subpopulations
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461764Hom.: 0 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 727200 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152170Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74338 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.632C>T (p.T211I) alteration is located in exon 8 (coding exon 7) of the NPAS2 gene. This alteration results from a C to T substitution at nucleotide position 632, causing the threonine (T) at amino acid position 211 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at